theory clinical_104_10
imports Main

begin

typedecl entity
typedecl event

consts
  Inhibitor :: "entity ⇒ bool"
  TargetedTo :: "entity ⇒ entity ⇒ bool"
  HER2_Kinase_Domain :: "entity ⇒ bool"
  Trastuzumab_Resistance :: "entity ⇒ bool"
  HER2_Activating_Mutation :: "entity ⇒ bool"
  Overcome :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  InducedBy :: "event ⇒ entity ⇒ bool"
  HER2_V777L :: "entity ⇒ bool"
  Trastuzumab :: "entity ⇒ bool"
  Extracellular_Kinase_Domain :: "entity ⇒ bool"
  Intracellular_Kinase_Domain :: "entity ⇒ bool"
  Resistance :: "event ⇒ bool"
  Cause :: "event ⇒ entity ⇒ bool"
  Bind :: "event ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Targeting :: "entity ⇒ bool"
  HER_V777L_Mutation :: "entity ⇒ bool"
  Tyrosine_Kinase_Inhibitor :: "entity ⇒ bool"
  HER2_V777L_Mutation :: "entity ⇒ bool"
  NecessaryStep :: "event ⇒ event ⇒ bool"
  Treatment_Resistance :: "entity ⇒ bool"
  CriticalFactor :: "event ⇒ event ⇒ bool"
  AimedAt :: "event ⇒ event ⇒ bool"
  RelatedTo :: "event ⇒ event ⇒ bool"

(* Explanation 1: An irreversible inhibitor that is targeted to the HER2 kinase domain should overcome trastuzumab resistance that has been induced by a HER2-activating mutation. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. Inhibitor x ∧ TargetedTo x y ∧ HER2_Kinase_Domain y ∧ Trastuzumab_Resistance z ∧ HER2_Activating_Mutation z ∧ Overcome e1 ∧ Agent e1 x ∧ Patient e1 z ∧ InducedBy e2 z"

(* Explanation 2: HER2 V777L may cause resistance to trastuzumab, as trastuzumab binds to the extracellular kinase domain, whereas the mutation is in the intracellular kinase domain. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. HER2_V777L x ∧ Trastuzumab y ∧ Extracellular_Kinase_Domain z ∧ Intracellular_Kinase_Domain z ∧ Resistance e1 ∧ Cause e1 x ∧ Patient e1 y ∧ Bind e2 ∧ Agent e2 y ∧ Patient e2 z ∧ In x z"

(* Explanation 3: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor can directly overcome the resistance caused by the HER2 V777L mutation, and this action is a necessary step in overcoming treatment resistance. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. Targeting x ∧ HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x ∧ Resistance z ∧ HER2_V777L_Mutation y ∧ Overcome e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Cause e2 y ∧ NecessaryStep e2 e1"

(* Explanation 4: Directly overcoming the resistance caused by the HER2 V777L mutation is a critical factor in overcoming treatment resistance. *)
axiomatization where
  explanation_4: "∃x y e1 e2. Resistance x ∧ HER2_V777L_Mutation y ∧ Treatment_Resistance y ∧ Overcome e1 ∧ Agent e1 x ∧ Patient e1 y ∧ CriticalFactor e2 e1"

(* Explanation 5: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor is specifically aimed at overcoming the resistance caused by the HER2 V777L mutation, which is a critical factor in overcoming treatment resistance. *)
axiomatization where
  explanation_5: "∃x y z e1 e2. Targeting x ∧ HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x ∧ Resistance z ∧ HER2_V777L_Mutation y ∧ Overcome e1 ∧ Agent e1 x ∧ Patient e1 z ∧ AimedAt e2 e1 ∧ CriticalFactor e2 e1"

(* Explanation 6: Overcoming the resistance caused by the HER2 V777L mutation is directly related to overcoming overall treatment resistance. *)
axiomatization where
  explanation_6: "∃x y e1 e2. Resistance x ∧ HER2_V777L_Mutation y ∧ Treatment_Resistance y ∧ Overcome e1 ∧ Agent e1 x ∧ Patient e1 y ∧ RelatedTo e2 e1"

theorem hypothesis:
  assumes asm: "Targeting x ∧ HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x"
  (* Hypothesis: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance. *)
  shows "∃x y e. Targeting x ∧ HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x ∧ Overcome e ∧ Agent e x ∧ Patient e y"
proof -
  (* From the premise, we have known information about targeting, HER V777L mutation, and tyrosine kinase inhibitor. *)
  from asm have "Targeting x ∧ HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x" <ATP>
  (* There is a logical relation Implies(F, G), which states that targeting HER V777L mutation with an irreversible tyrosine kinase inhibitor implies directly overcoming resistance caused by HER2 V777L mutation. *)
  (* F is from explanatory sentence 3, G is from explanatory sentence 3. *)
  (* We already have F, so we can infer G. *)
  then have "Overcome e ∧ Agent e x ∧ Patient e y" <ATP>
  then show ?thesis <ATP>
qed

end
